Clarity Pharmaceuticals Ltd.ASX: CU6

Ceasing to be a substantial holder

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX ·

605 Page 1 12-Aug-2026 To Company Name/Scheme ACN/ARSN 1. Details of substantial holder (1) Name ACN/ARSN (if applicable) The holder ceased to be a substantial holder on 10/08/2026 The previous notice was given to the company on 07/08/2026 The previous notice was dated 05/08/2026 2....

View Attachment

6ix hasn’t read this filing yet.

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

Later from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases